Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing.

about

Magnetic nanoformulations for prostate cancer.Magnetite-Gold nanohybrids as ideal all-in-one platforms for theranostics

P2860

Q39319113-3500C229-84F5-4C80-82DB-7748996034A4 Q57181751-A3878AEF-C117-4177-BAD4-B88285B89C0B

P2860

Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing.

Item

http://www.wikidata.org/entity/Q38742432

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Nanohybride Materials Based on ...... ynthesis and In Vitro Testing.

@en

type

Item

label

Nanohybride Materials Based on ...... ynthesis and In Vitro Testing.

@en

prefLabel

Nanohybride Materials Based on ...... ynthesis and In Vitro Testing.

@en

P1476

Nanohybride Materials Based on ...... Synthesis and In Vitro Testing

@en

P2093

A E Machulkin

http://www.w3.org/2001/XMLSchema#string

A G Mazhuga

http://www.w3.org/2001/XMLSchema#string

A G Savchenko

http://www.w3.org/2001/XMLSchema#string

A S Garanina

http://www.w3.org/2001/XMLSchema#string

E K Beloglazkina

http://www.w3.org/2001/XMLSchema#string

O A Zhironkina

http://www.w3.org/2001/XMLSchema#string

V E Kotelyanskii

http://www.w3.org/2001/XMLSchema#string

P2860

In vivo cancer targeting and imaging with semiconductor quantum dots

Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound.

The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways.

Targeted, activatable, in vivo fluorescence imaging of prostate-specific membrane antigen (PSMA) positive tumors using the quenched humanized J591 antibody-indocyanine green (ICG) conjugate.

In Vivo Molecular MRI Imaging of Prostate Cancer by Targeting PSMA with Polypeptide-Labeled Superparamagnetic Iron Oxide Nanoparticles.

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.

Magnetic nanoparticles for cancer diagnosis and therapy.

A current perspective of autophagosome biogenesis.

PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer.

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand.

P2888

s10517-016-3490-3

P304

706-710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10517-016-3490-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

161

http://www.w3.org/2001/XMLSchema#string

P50

Nikolay Zyk

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003119968

http://www.w3.org/2001/XMLSchema#string

P698

27704352

http://www.w3.org/2001/XMLSchema#string

Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing.

about

P2860

P2860

Nanohybride Materials Based on Magnetite-Gold Nanoparticles for Diagnostics of Prostate Cancer: Synthesis and In Vitro Testing.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698